Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F13AF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,737
Award facts
- Contract value 100% obligated
- $14,736.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,736.64 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of RINVOQ ER 15 MG tablets in quantities of 30 units. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of November 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement requirements for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp demonstrates significant capability in fulfilling diverse therapeutic pharmaceutical needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract mechanism.
Quick answers
Who was awarded contract SPE2DR26F13AF?
SPE2DR26F13AF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F13AF worth?
The government has obligated $14,737 on SPE2DR26F13AF.
Is contract SPE2DR26F13AF an order under another contract?
Yes. SPE2DR26F13AF is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13AF competed?
The extent of competition for SPE2DR26F13AF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award